« Back
Home /
Mps1-IN-2

Mps1-IN-2

Manufacturer	MedChem Express
Category	Oncology Neuroscience Molecular Targets for Neuroscience By Cell Type Blastoma Carcinoma Mesothelioma Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	50 mg
Item no.	HY-13994-50mg
Targets	Mps1; Polo-like Kinase (PLK)
CASRN	1228817-38-6
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Mps1-IN-2 is a potent, selective and ATP-competitive dual Mps1/Plk1 inhibitor, with an IC50 and a Kd of 145 nM and 12 nM for Mps1 and a Kd of 61 nM for Plk1.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	480.60
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : 13.33 mg/mL (ultrasonic)
Manufacturers Target	Mps1; Polo-like Kinase (PLK)
Pathway	Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13994-50mg-safety-datasheet.pdf